Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
BGC Group reaffirmed its previously stated financial outlook for the third quarter ending September 30, 2026. The company maintained its existing ranges for both revenue and pre-tax Adjusted Earnings as originally issued on July 30, 2026.
The FDA has approved Mirum Pharmaceuticals' Atebrioz (zilurgisertib) for the treatment of fibrodysplasia ossificans progressiva (FOP) in patients aged 12 and older. The drug, licensed from Incyte, is a first-of-its-kind oral ALK2 inhibitor designed to reduce new heterotopic ossification (abnormal bone formation). Mirum expects the product to be commercially available in the U.S. in October 2026.
Ainos Licensing Deal with BioPhoenix Co., Ltd. Worth $10M
Ainos entered into a global exclusive license agreement with BioPhoenix for its VELDONA low-dose oral interferon alpha technology platform for Sjögren’s Disease and Thrombocytopenia. Ainos will receive an upfront fee of $600,000 and is eligible for up to $10.0 million in total fees if additional indications are licensed, plus 25% of net sublicensing revenue. BioPhoenix will assume all clinical and regulatory funding and execution for the licensed indications.
Keros Therapeutics announced the dosing of the first patient in its Phase 2 clinical trial evaluating rinvatercept for the treatment of Duchenne muscular dystrophy (DMD). The open-label, multi-cohort trial will assess safety, tolerability, and functional improvements in ambulatory and non-ambulatory patients, with initial data expected in the first half of 2027.
SHF Holdings (Safe Harbor Financial) has approved a 1-for-12 reverse stock split of its common stock, effective September 30, 2026. The split aims to consolidate every twelve outstanding shares into one share to adjust the trading price on the Nasdaq Stock Market. Stockholders previously approved the measure at a special meeting held in November 2025.
Matinas BioPharma implemented a one-for-fifteen (1:15) reverse stock split of its common stock effective September 28, 2026. The split was previously approved by stockholders at the 2025 annual meeting and is intended to adjust the share price for continued trading on the NYSE American.
Strategy Inc raised $246.2 million in net proceeds through the sale of 1,469,165 shares of Class A Common Stock under its at-the-market (ATM) offering program between September 21 and September 27, 2026. The company utilized $142.7 million of the proceeds to purchase 1,665 additional bitcoins and $103.5 million to fund repurchases of its STRC preferred stock. As of September 27, 2026, the company held a total of 847,666 bitcoins acquired at an aggregate purchase price of approximately $63.95 billion.
Strive, Inc. provided an operational update disclosing the purchase of 1,107 bitcoin between September 21 and September 25, 2026, at an average price of $85,396 per token. The company also reported updated treasury holdings, showing a total of 27,462 bitcoin and $248.8 million in cash and cash equivalents as of September 25, 2026.
Lakeshore Acquisition III M&A Deal with CPRO Electronics Co. Ltd.
Lakeshore Acquisition III Corp. has extended the deadline to complete its initial business combination from October 1, 2026, to November 1, 2026. The extension was triggered by a $67,500 payment into the company's trust account by its merger partner, CPRO Electronics Co. Ltd., pursuant to their existing merger agreement.
Qfin Holdings Insider Andrew Y. Yan Sells $4.89M of Stock
Andrew Y. Yan sold 656,700 shares of Qfin Holdings, Inc. at $7.36 to $7.52 a share (average $7.44) in 2 transactions, worth $4.89M in total between Sep 24, 2026 and Sep 25, 2026. Shares held after the trade: 0 (-100.0%).
TransDigm Group Signs $1.07B M&A Deal with Prince & Izant
TransDigm Group completed the acquisition of Prince & Izant, a manufacturer of highly engineered brazing alloys and specialty metal components, for approximately $1.066 billion in cash. The acquisition, financed with cash on hand, expands TransDigm's presence in the aerospace and defense aftermarket and is expected to generate $390 million in revenue for calendar year 2026.
News Corp provided a daily update on its $1 billion stock repurchase program as required by Australian Securities Exchange (ASX) rules. The program authorizes the company to buy back outstanding shares of both Class A and Class B common stock from time to time in the open market. This filing specifically reports daily transaction activity for Class A common stock under the 2025 Repurchase Program.
Valley National Bancorp Signs $340M M&A Deal with Bluevine Inc.
Valley National Bancorp (VLY) has entered into a definitive agreement to acquire Bluevine Inc., a digital banking platform for small businesses, for approximately $340 million. The deal consists of $255 million in cash and approximately 6.3 million shares of Valley common stock, aimed at enhancing Valley's core funding base and accelerating its digital and AI strategy. Bluevine brings approximately $2.1 billion in low-cost deposits and 175,000 active small business customers to the combined organization.
Soluna Holdings Partnership with Bitdeer Technologies Group
Soluna Holdings expanded its co-mining partnership with Bitdeer Technologies Group to deploy an additional 7 MW of Bitcoin mining equipment at its Project Kati 1 site in Texas. This amendment brings Bitdeer's total deployment at the site to 35 MW (approximately 2.42 EH/s), fully subscribing the site's K1BC phase under a revenue-sharing structure.
A federal jury in West Virginia awarded Ramaco Resources $30 million in damages following a retrial regarding the wrongful denial of an insurance claim related to a 2018 silo failure. The award includes $27.5 million for net economic loss and $2.5 million for aggravation and inconvenience, with a final determination on attorney's fees still pending from the Court.
Counterparty
Federal Insurance Company and ACE American Insurance Company (Chubb)
Hut 8 $1.07B Debt Financing with JPMorgan Chase Bank, N.A.
Hut 8 Corp. entered into a $1.07 billion senior secured revolving credit facility with a syndicate of lenders led by JPMorgan Chase Bank. The facility includes a $1.07 billion letter of credit sublimit and is intended to provide non-dilutive liquidity for general corporate purposes and to support collateral requirements for AI data center development.
Eton Pharmaceuticals has launched IMPAVIDO (miltefosine) capsules in the United States for the treatment of visceral, cutaneous, and mucosal leishmaniasis. The company has integrated the product into its Eton Cares rare disease commercial infrastructure, providing patient support services and centralized distribution through Anovo Specialty Pharmacy.
Moleculin Biotech announced the peer-reviewed publication of a pooled cardiac safety analysis of its drug candidate Annamycin in Frontiers in Cardiovascular Medicine. The analysis of 90 patients across five clinical trials found no clinical or subclinical evidence of cardiotoxicity, even at cumulative doses exceeding traditional anthracycline limits.
Counterparty
Cleveland Clinic
“Publication of this comprehensive pooled analysis in a peer-reviewed cardiovascular medicine journal provides additional validation of the cardiac safety profile we have observed with Annamycin across our clinical development program. For decades, the clinical utility of anthracyclines has been limited by cumulative cardiotoxicity and associated lifetime dose limits. The absence of detectable cardiac toxicity in patients receiving cumulative doses of Annamycin beyond those traditional thresholds supports our continued development of Annamycin and its potential to address an important limitation of the anthracycline class.”
Walter Klemp, Chairman and Chief Executive Officer of Moleculin
Flutter Entertainment has ceased its sports betting and iGaming operations in Brazil following a provisional executive order from the Brazilian Government banning such activities. The company expects this cessation to reduce its 2026 revenue by approximately $70 million and adjusted EBITDA by $20 million if operations remain suspended for the rest of the year.
Vestis Corporation appointed Russell Tiejema as Executive Vice President and Chief Financial Officer, effective September 28, 2026. His compensation package includes a $700,000 base salary, a 100% target bonus, and a one-time sign-on equity award valued at $2.5 million. The company also reaffirmed its fiscal full-year 2026 financial outlook in connection with the announcement.
Jaguar Health $3.4M Debt Financing with Streeterville Capital, LLC
Jaguar Health entered into exchange agreements with Streeterville Capital to reduce the outstanding balance of a 2021 secured promissory note by $3.4 million. In exchange for this debt reduction, the company issued 481,584 shares of its common stock to the lender. The transaction was conducted as a privately negotiated exchange exempt from registration under Section 3(a)(9) of the Securities Act.
Damora Therapeutics Director, President and CEO Jennifer Jarrett Buys $253K of Stock
Jennifer Jarrett, Director, President and CEO, bought 12,500 shares of Damora Therapeutics, Inc. at $20.23 a share, worth $253K in total on Sep 25, 2026. Shares held after the trade: 512,500 (+2.5%).
Coeur Mining, Inc. has posted an updated corporate presentation to its website, which was prepared for the Mining Forum Americas. The presentation provides a strategic and operational update for investors and is filed under Regulation FD disclosure.
Perpetua Resources Corp. published an updated investor presentation on September 28, 2026, for use in upcoming investor relations activities. The presentation is available on the company's website and was furnished under Item 7.01 of Form 8-K.
Ftai Infrastructure Signs $255M M&A Deal with DRUbit Holdings LLC
FTAI Infrastructure's subsidiary entered into a definitive agreement to acquire the Port Arthur Terminal and a 50% interest in a Diluent Recovery Unit from USD Group LLC for $255 million. The acquisition includes an integrated origin-to-destination logistics platform for crude oil shipment under a long-term, take-or-pay contract with an investment-grade counterparty. The deal is expected to generate approximately $50 million of annual EBITDA and close in the fourth quarter of 2026.
U.S. GoldMining Inc. announced the completion of its 2026 surface exploration program at the Whistler Gold-Copper Project in Alaska, which included geological mapping and rock chip sampling. The program identified new outcrop zones of gold-copper porphyry-style mineralization and expanded the target pipeline at the Whistler Orbit, Island Mountain, and Muddy Creek areas. Assay results for 58 rock grab samples are currently pending as the company works to delineate high-priority targets for future drill testing.
Gray Media raised its Q3 2026 financial guidance, specifically increasing its political advertising revenue expectations to $188-$195 million and lifting the low end of its total revenue range to $950-$965 million. The update was provided in connection with upcoming lender meetings to refinance its credit facility and presentations to institutional investors. The company also lowered its expected corporate and administrative expenses for the quarter.
Microbot Medical Inc. disseminated a press release on September 25, 2026, providing an update on its growth strategies. The filing was made under Item 7.01 (Regulation FD Disclosure) to communicate strategic developments to investors.
A jury awarded $5.7 billion in damages to Taction Technology, Inc. in a patent litigation case against Apple Inc. in which Burford Capital has a financial entitlement. If the verdict were paid in full, Burford's entitlement would be approximately $1.4 billion, though the company cautioned that the amount is subject to significant post-trial and appellate risk.
Flash Sports & Media Holdings, Inc. announced the cancellation of its 2026 annual meeting of stockholders, which was originally scheduled for September 28, 2026. The company also reported that its common stock has commenced trading on the OTCID market under the symbol 'FLZH' while it awaits a Nasdaq continued listing hearing scheduled for October 6, 2026.